SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    D. Wu, S.-Y. Hou, S. Zhao, L.-X. Hou, T. Jiao, N.-N. Xu, N. Zhang, Efficacy and safety of interleukin-17 antagonists in patients with plaque psoriasis: a meta-analysis from phase 3 randomized controlled trials, Journal of the European Academy of Dermatology and Venereology, 2017, 31, 5
  2. 2
    P. Kerkhof, L. Guenther, A.B. Gottlieb, M. Sebastian, J.J. Wu, P. Foley, A. Morita, O. Goldblum, L. Zhang, J. Erickson, S. Ball, P. Rich, Ixekizumab treatment improves fingernail psoriasis in patients with moderate-to-severe psoriasis: results from the randomized, controlled and open-label phases of UNCOVER-3, Journal of the European Academy of Dermatology and Venereology, 2017, 31, 3
  3. 3
    Radomir Reszke, Jacek C Szepietowski, Secukinumab in the treatment of psoriasis: an update, Immunotherapy, 2017, 9, 3, 229

    CrossRef

  4. 4
    Alice Gottlieb, John Sullivan, Martijn van Doorn, Alexey Kubanov, Ruquan You, Anne Parneix, Sophie Hugot, Marina Milutinovic, Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE, a randomized controlled trial, Journal of the American Academy of Dermatology, 2017, 76, 1, 70

    CrossRef

  5. 5
    Theresa N. Canavan, Craig A. Elmets, Wendy L. Cantrell, John M. Evans, Boni E. Elewski, Anti-IL-17 Medications Used in the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review, American Journal of Clinical Dermatology, 2016, 17, 1, 33

    CrossRef

  6. You have free access to this content6
    Laura C. Coates, Arthur Kavanaugh, Philip J. Mease, Enrique R. Soriano, Maria Laura Acosta-Felquer, April W. Armstrong, Wilson Bautista-Molano, Wolf-Henning Boehncke, Willemina Campbell, Alberto Cauli, Luis R. Espinoza, Oliver FitzGerald, Dafna D. Gladman, Alice Gottlieb, Philip S. Helliwell, M. Elaine Husni, Thorvardur J. Love, Ennio Lubrano, Neil McHugh, Peter Nash, Alexis Ogdie, Ana-Maria Orbai, Andrew Parkinson, Denis O'Sullivan, Cheryl F. Rosen, Sergio Schwartzman, Evan L. Siegel, Sergio Toloza, William Tuong, Christopher T. Ritchlin, Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis, Arthritis & Rheumatology, 2016, 68, 5
  7. 7
    Marcel C. Pasch, Nail Psoriasis: A Review of Treatment Options, Drugs, 2016, 76, 6, 675

    CrossRef

  8. 8
    Tarannum Jaleel, Craig Elmets, Allison Weinkle, Sama Kassira, Boni Elewski, Secukinumab (AIN-457) for the treatment of Psoriasis, Expert Review of Clinical Pharmacology, 2016, 9, 2, 187

    CrossRef

  9. 9
    Andrea Chiricozzi, Rosita Saraceno, Lucia Novelli, Monika Fida, Francesco Caso, Raffaele Scarpa, Luisa Costa, Roberto Perricone, Marco Romanelli, Sergio Chimenti, Maria Sole Chimenti, Small molecules and antibodies for the treatment of psoriasis: a patent review (2010–2015), Expert Opinion on Therapeutic Patents, 2016, 26, 7, 757

    CrossRef

  10. 10
    R.G. Langley, P. Rich, A. Menter, G. Krueger, O. Goldblum, Y. Dutronc, B. Zhu, H. Wei, G.S. Cameron, M.P. Heffernan, Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis, Journal of the European Academy of Dermatology and Venereology, 2015, 29, 9
  11. 11
    Duo Li, Bin Guo, Haijing Wu, Lina Tan, Christopher Chang, Qianjin Lu, Interleukin-17 in systemic lupus erythematosus: A comprehensive review, Autoimmunity, 2015, 48, 6, 353

    CrossRef

  12. 12
    Nicole M. van Besouw, Kadir Caliskan, Annemiek M.A. Peeters, Mariska Klepper, Marjolein Dieterich, Lex P.W.M. Maat, Willem Weimar, Olivier C. Manintveld, Carla C. Baan, Interleukin-17–producing CD4+ cells home to the graft early after human heart transplantation, The Journal of Heart and Lung Transplantation, 2015, 34, 7, 933

    CrossRef

  13. 13
    Dennis J. Cada, Danial E. Baker, Shannon G. Panther, Kyle Ingram, Secukinumab, Hospital Pharmacy, 2015, 50, 8, 714

    CrossRef

  14. 14
    Sandra Philipp, Teil 1: neue gegen IL-17 und IL-23 gerichtete Therapien, hautnah dermatologie, 2015, 31, 1, 30

    CrossRef